Second Life Sciences GenAI Council Expands Global Perspective
Comunicato Precedente
Comunicato Successivo
The European meeting will focus on key topics, such as:
Aman Wasan, CEO of ArisGlobal, said: "After an incredible first session in the USA, this first European assembly of the Life Sciences GenAI Council will go deeper into practical applications of GenAI. Our team and our Council members are invigorated to continue open dialogue on the challenges, approaches, and maturity related to the adoption of GenAI and LLM features. Partnering with top global pharmaceutical companies and the best AI technologists to rapidly deploy new solutions that transform critical business operations in life sciences, is deeply meaningful work for all of us at ArisGlobal."
The global GenAI Council is an exclusive peer group whose remit is to define and shape the targeted use of next-generation artificial intelligence and machine learning (AI/ML) innovation, particularly in the form of Generative AI (GenAI), across the Life Sciences research and development (R&D) lifecycle. Council members, appointed by invitation only, meet quarterly in major regions around the world.
![Second Life Sciences GenAI Council Expands Global Perspective](https://mma.prnewswire.com/media/1510670/ArisGlobal_Logo.jpg)
About ArisGlobal
ArisGlobal, an innovative life sciences technology company and creator of LifeSphere, is transforming the way today's most successful life sciences companies develop breakthroughs and bring new products to market. Headquartered in
the United States, ArisGlobal has regional offices in
Europe, India,
Japan, and China. For more updates, follow ArisGlobal on LinkedIn. www.arisglobal.com.
Logo - https://mma.prnewswire.com/media/1510670/ArisGlobal_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/second-life-sciences-genai-council-expands-global-perspective-302112699.html
![](https://rt.prnewswire.com/rt.gif?NewsItemId=EN84207&Transmission_Id=202404100400PR_NEWS_EURO_ND__EN84207&DateId=20240410)